FAQ: Is CAR T-cell therapy immunotherapy?

Yes, CAR T-cell therapy is a form of immunotherapy. It utilizes the patient’s own immune system to fight cancer. T-cells, a type of white blood cell, are extracted from the patient and genetically engineered to express chimeric antigen receptors (CARs). These CARs enable the T-cells to recognize and target specific antigens present on cancer cells. Once infused back into the patient, the CAR T-cells can selectively attack cancer cells, enhancing the immune response against the disease. This targeted approach distinguishes CAR T-cell therapy from traditional chemotherapy and radiation therapy, which can have broader effects on healthy cells.